Opens in a new tab

Breaking news

Mave Health’s Neuromodulation Headset: Pioneering A New Frontier In Mental Health Technology

Mave Health has introduced a $495 neuromodulation headset designed to support attention, mood regulation and stress management. The device is positioned as a consumer product and does not require medical regulatory approval.

Innovation Driven By Personal Tragedy

The company was founded in 2023 by Dhawal Jain, together with Jai Sharma and Aman Kumar. Jain said the idea was shaped by personal experience during the COVID-19 period, which highlighted challenges in measuring progress in mental health treatment. Focus shifted to neuromodulation as a way to introduce measurable outcomes in areas such as stress and productivity.

Leveraging TDCS For Lifestyle Enhancement

The company was founded in 2023 by Dhawal Jain, together with Jai Sharma and Aman Kumar. Jain said the idea was shaped by personal experience during the COVID-19 period, which highlighted challenges in measuring progress in mental health treatment. Focus shifted to neuromodulation as a way to introduce measurable outcomes in areas such as stress and productivity.

Rigorous Beta Testing And Preliminary Results

During private beta trials conducted between 2024 and 2025, more than 500 users reported significant improvements. Nearly 80% of participants experienced a 60% boost in productivity, while 75% noted a reduction in stress levels within two months of use. Complemented by a robust app that tracks metrics such as mood, focus, stress, and heart rate variability, the system offers insights into long-term trends, allowing both users and the company to measure its impact accurately.

Expert Perspectives And Ongoing Studies

External experts have highlighted both potential and limitations. Himanshu Nirvan, a psychiatrist who consulted on the project, pointed to the device’s accessibility and portability. Leigh Elkins Charvet of NYU Grossman School of Medicine noted that while tDCS is considered safe in controlled settings, broader consumer use requires further evidence and clearer guidelines. The company has conducted four observational studies involving 200 participants, with results currently under academic review.

Strategic Market Positioning And Investment Milestones

By marketing the headset as a non-medical lifestyle device, Mave Health aims to bypass the protracted regulatory pathways and reach a wider audience. The company’s innovative approach is supported by recent seed funding of $2.1 million led by Blume Ventures, with notable participation from investors such as Tesla Autopilot AI lead Dhaval Shroff. With under $3 million raised in total, Mave Health is set to begin shipping its first batch to customers in the U.S. and India in April 2026.

This evolution not only marks a turning point in consumer mental health technology but also underscores the broader trend of integrating advanced neuromodulation techniques into everyday wellness routines. As research continues and more clinical evidence emerges, the future of mental health management could very well be defined by such portable, scalable innovations.

 

Cyprus Hotel Association Expands Membership To 235 Businesses In Its 90th Anniversary Year

The Cyprus Hotel Association (Pasyxe) has expanded its membership to 235 hotels and accommodation businesses, adding 17 members in the year it marks its 90th anniversary.

The association said its members now represent 67.3% of all hotel beds in Cyprus, strengthening its position as an advocate for businesses across the island’s tourism sector.

A Broader Presence Across Cyprus

Ten of the new members are in the Famagusta district, including seven in Protaras. Four properties joined in the Paphos district, while Nicosia, Larnaca and Limassol each added one member.

The intake spans five five-star properties, five four-star hotels, four three-star hotels and three holiday accommodation complexes. Pasyxe said the additions broaden its representation across both accommodation categories and regions.

New Members From Protaras To Paphos

In Protaras, the five-star Sunrise Emerald Hotel joined alongside the four-star Leonardo Crystal Cove Hotel & Spa and Evalena Beach Hotel. The three-star Protaras Plaza Hotel, Cavo Zoe Seaside Hotel and Blue Ivy Hotel & Suites also became members, as did the Grade B Vrissaki Hotel Apartments.

In Ayia Napa, the new members are the five-star Nissi Blu Resort and the Grade A Evabelle Napa Hotel Apartments. The Grade A Malama Holiday Village in Paralimni completes the Famagusta district additions.

The Paphos district’s new members include two five-star properties: Louis Cali Resort & Spa in Peyia and NALU Latchi Leonardo Limited Edition in Latchi. The four-star Paphos Hills by Brown and the three-star Serbellas Boutique Hotel in Kissonerga also joined.

Elsewhere, the five-star Amyth of Nicosia and four-star Leonardo Boutique Hotel Larnaca joined the association. The new member in the Limassol district is the four-star Pendeli Resort in Pano Platres.

A Collective Voice For The Industry

“The strength of Pasyxe lies in its members,” the association said, adding that each addition creates opportunities for businesses to collaborate and gives the hotel industry a stronger collective voice.

Pasyxe said the expansion carries added significance in its 90th anniversary year. It described nine decades of collective work as a foundation for responding to the hotel industry’s changing needs and representing a wider range of businesses.

The association said it looked forward to working with its new members to improve Cyprus’s visitor offering, strengthen the island’s competitiveness as a destination and support the hotel industry’s long-term, sustainable growth.

Uol
eCredo
The Future Forbes Realty Global Properties
Aretilaw firm

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter